Literature DB >> 15456924

Role of oxidant stress in lawsone-induced hemolytic anemia.

David C McMillan1, Snehal D Sarvate, John E Oatis, David J Jollow.   

Abstract

Lawsone (2-hydroxy-1,4-naphthoquinone) is the active ingredient of henna (Lawsonia alba), the crushed leaves of which are used as a cosmetic dye. Application of henna can induce a severe hemolytic anemia, and lawsone is thought to be the causative agent. Administration of lawsone to rats has been shown to induce a hemolytic response that is associated with oxidative damage to erythrocytes. However, direct exposure of isolated erythrocytes to lawsone did not provoke oxidative damage, suggesting that lawsone must undergo extra-erythrocytic bioactivation in vivo. In the present study, the survival of rat 51Cr-labeled erythrocytes in vivo after in vitro exposure to lawsone and its hydroquinone form, 1,2,4-trihydroxynaphthalene (THN) has been examined. Neither lawsone nor THN were directly hemolytic or methemoglobinemic, even at high concentrations (>3 mM). Lawsone had no effect on erythrocytic GSH levels, whereas THN (3 mM) induced a modest depletion (approximately 30%). Cyclic voltammetry revealed that the lack of hemotoxicity of lawsone was associated with a poor capacity to undergo redox cycling. In contrast, ortho-substituted 1,4-naphthoquinones without a 2-hydroxy group, such as 2-methyl- and 2-methoxy-1,4-naphthoquinone, were redox active, were able to deplete GSH, and were direct-acting hemolytic agents. An oxidant stress-associated hemolytic response to lawsone could be provoked, however, if it was incubated with GSH-depleted erythrocytes. The data suggest that lawsone is a weak direct-acting hemolytic agent that does not require extra-erythrocytic metabolism to cause hemotoxicity. Thus, the hemolytic response to henna may be restricted to individuals with compromised antioxidant defenses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456924     DOI: 10.1093/toxsci/kfh288

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

1.  Oxidation of hemoglobin and redistribution of band 3 promote erythrophagocytosis in visceral leishmaniasis.

Authors:  Sudipa Saha Roy; Kaustav Dutta Chowdhury; Gargi Sen; Tuli Biswas
Journal:  Mol Cell Biochem       Date:  2008-09-06       Impact factor: 3.396

2.  Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes - Role of Redox Stress and Band 3 Modifications.

Authors:  Paolo Arese; Valentina Gallo; Antonella Pantaleo; Franco Turrini
Journal:  Transfus Med Hemother       Date:  2012-09-17       Impact factor: 3.747

3.  Evaluation of the effects of hair colouring products on the oxidative status in rats.

Authors:  Hülya Nazik; Duygun Altintaş Aykan; Muhammed Seyithanoğlu; Perihan Öztürk; Mehmet Kamil Mülayim; Hakan Nazik
Journal:  Postepy Dermatol Alergol       Date:  2020-11-07       Impact factor: 1.837

4.  Comparison of the Effect of Native 1,4-Naphthoquinones Plumbagin, Menadione, and Lawsone on Viability, Redox Status, and Mitochondrial Functions of C6 Glioblastoma Cells.

Authors:  Daiva Majiene; Jolita Kuseliauskyte; Arturas Stimbirys; Aiste Jekabsone
Journal:  Nutrients       Date:  2019-06-07       Impact factor: 5.717

5.  Marine Polyhydroxynaphthoquinone, Echinochrome A: Prevention of Atherosclerotic Inflammation and Probable Molecular Targets.

Authors:  Aleksandr A Artyukov; Elena A Zelepuga; Larisa N Bogdanovich; Natalia M Lupach; Vyacheslav L Novikov; Tatyana A Rutckova; Emma P Kozlovskaya
Journal:  J Clin Med       Date:  2020-05-15       Impact factor: 4.241

Review 6.  Mannich bases derived from lawsone and their metal complexes: synthetic strategies and biological properties.

Authors:  Abolfazl Olyaei; Mahdieh Sadeghpour; Mehdi Khalaj
Journal:  RSC Adv       Date:  2020-08-17       Impact factor: 3.361

7.  In Vitro Activity of 2-methoxy-1,4-naphthoquinone and Stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against Multiple Antibiotic-Resistant Helicobacter pylori.

Authors:  Yuan-Chuen Wang; Wan-Yu Li; Deng-Chyang Wu; Jeh-Jeng Wang; Cheng-Hsun Wu; Jyun-Ji Liao; Cheng-Kun Lin
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.